Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Enoxaparin price, strengths & recalls

Generic of Lovenox

Pharmacies pay $29.89 for 4 mL of Enoxaparin 100 mg/mL, 0.4 mL prefilled syringe this week, and from $25.61 to $90.76 across its 8 priced strengths and forms. 13 manufacturers make it. It is in shortage (being discontinued). 3 recalls are ongoing. Its official label last changed on September 21, 2026.

Being discontinued3 open recallsGeneric
Pharmacies pay$29.89for 4 mL of 100 mg/mL, 0.4 mL prefilled syringe-4.0% in 4 weeks
Fair cash price
$44.87
Strengths
8
Makers
13
Updated
Nov 11

Enoxaparin price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
100 mg/mL injection$9.98$29.93 / 3 mL+1.0%-12.7%
100 mg/mL, 0.3 mL prefilled syringe$8.54$25.61 / 3 mL-6.5%-7.1%
100 mg/mL, 0.4 mL prefilled syringe$7.47$29.89 / 4 mL-4.0%-15.0%
100 mg/mL, 0.6 mL prefilled syringe$7.31$43.85 / 6 mL-1.9%-15.9%
100 mg/mL, 0.8 mL prefilled syringe$7.00$55.99 / 8 mL+4.7%-22.7%
100 mg/mL, 1 mL prefilled syringe$6.78$67.83 / 10 mL+5.1%-23.0%
150 mg/mL, 0.8 mL prefilled syringe$10.57$84.56 / 8 mL+1.5%-24.9%
150 mg/mL, 1 mL prefilled syringe$9.08$90.76 / 10 mL+1.9%-28.7%

Brand names of enoxaparin

A brand and its generic share the active ingredient; the generic is almost always far cheaper.

Supply status: shortages & recalls

In shortage24 products are short or being discontinued
3 ongoing recalls7 recalls on record, latest Sep 3, 2025

Shortages

  • Lovenox, Injection, 40 mg/.4 mL (NDC 0075-0620-40)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Lovenox, Injection, 30 mg/.3 mL (NDC 0075-8013-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Enoxaparin Sodium, Injection, 40 mg/.4 mL (NDC 0955-1004-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Lovenox, Injection, 60 mg/.6 mL (NDC 0075-8016-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Enoxaparin Sodium, Injection, 120 mg/.8 mL (NDC 0955-1012-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Enoxaparin Sodium, Injection, 100 mg/1 mL (NDC 0955-1010-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Lovenox, Injection, 100 mg/1 mL (NDC 0075-8020-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Enoxaparin Sodium, Injection, 150 mg/1 mL (NDC 0955-1015-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Lovenox, Injection, 150 mg/1 mL (NDC 0075-2915-01)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Lovenox, Injection, 60 mg/.6 mL (NDC 0075-0621-60)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Enoxaparin Sodium, Injection, 30 mg/.3 mL (NDC 0955-1003-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Enoxaparin Sodium, Injection, 300 mg/3 mL (NDC 0955-1016-01)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Showing the 6 most relevant of 7 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for enoxaparin? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedSeptember 21, 2026
Version23 of 18
EffectiveSep 17, 2026
Read the label

These highlights do not include all the information needed to use ENOXAPARIN SODIUM injection safely and effectively. See full prescribing information for ENOXAPARIN SODIUM injection.ENOXAPARIN SODIUM injection, for subcutaneous and intravenous useInitial U.S. Approval: 1993

This drug has a boxed warning

WARNING: SPINAL/EPIDURAL HEMATOMAS

Epidural or spinal hematomas may occur in patients who are anticoagulated with low molecular weight heparins (LMWH) or heparinoids and are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include:

Use of indwelling epidural catheters

Concomitant use of other drugs that affect hemostasis, such as non-steroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, and other anticoagulants

A history of traumatic or repeated epidural or spinal punctures

A history of spinal deformity or spinal surgery

Optimal timing between the administration of enoxaparin sodium and neuraxial procedures is not known

Monitor patients frequently for signs and symptoms of neurological impairment. If neurological compromise is noted, urgent treatment is necessary.

Consider the benefits and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated for thromboprophylaxis [see Warnings and Precautions (5.1) and Drug Interactions (7)].

WARNING: SPINAL/EPIDURAL HEMATOMAS

See full prescribing information for complete boxed warning.

Epidural or spinal hematomas may occur in patients who are anticoagulated with low molecular weight heparins (LMWH) or heparinoids and are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include:

Use of indwelling epidural catheters

Concomitant use of other drugs that affect hemostasis, such as non-steroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, and other anticoagulants

A history of traumatic or repeated epidural or spinal punctures

A history of spinal deformity or spinal surgery

Optimal timing between the administration of enoxaparin sodium and neuraxial procedures is not known

Monitor patients frequently for signs and symptoms of neurological impairment. If neurological compromise is noted, urgent treatment is necessary. (5.1, 7)

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA020164 · Sanofi Aventis US
First approved
March 29, 1993 (33 years ago)
Latest approved change
July 28, 2023
Approved label
PDF, Jul 31, 2023
Generic makers
9 approved generic applications on the market

Enoxaparin questions

How much does enoxaparin cost without insurance?

Pharmacies pay about $29.89 for 4 mL of enoxaparin 100 mg/mL, 0.4 mL prefilled syringe ($7.47 per mL). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $44.87. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

What is the brand name of enoxaparin?

Enoxaparin is sold as Lovenox. The generic has the same active ingredient and usually costs far less.

Is enoxaparin in shortage?

Yes. 24 products are listed as in shortage or being discontinued (being discontinued). See which ones.

Has enoxaparin been recalled?

7 recalls on record, 3 ongoing. Recalls name specific lots - check yours.

When did the enoxaparin label last change?

The official label was last updated on September 21, 2026 (version 23). See what changed.

Talk about enoxaparin

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.